On Thursday, Amedisys (Nasdaq: Amed) introduced that the US Division of Justice (DOJ) and attorneys common of Maryland, Illinois, New Jersey and New York have submitted a proposed ultimate opinion on the deliberate acquisition of Amedisys of the UnitedHealth Group. UnitedHealth and Amedisys agreed with the proposed ultimate judgment, which, if accepted, would resolve the opposition of the DOJ and […]